Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

The tobacco company could be left scrambling as a recent merger has the potential to elevate its competition.

Is Altria's Future Up in Smoke?

‎VANCOUVER, BC, June 1, 2022 /PRNewswire/ - PODA HOLDINGS, INC. ("PODA" or the "Company") (CSE: PODA) ‎(FSE: 99L) (OTC: PODAF) is pleased to announce that, further to its news release dated May 13, 2022 in respect of the proposed sale of all or substantially all of the Company's assets to Altria Client Services LLC ("ALCS"), a subsidiary of Altria Group, Inc. (NYSE: MO), it has filed a management information ‎circular (the "Circular") in connection with ‎the upcoming meeting of the holders of the Company's shares (the "Shareholders") called for June 22, 2022 ‎‎(the "Meeting").

PODA Announces Filing of Information Circular for Special Meeting

Equinor

Freeport-McMoRan

Lockheed Martin

Pfizer

PayPal

Roku

These undervalued large-cap stocks are trading at attractive valuations and are falling knives you probably want to catch. The post 7 Undervalued Large-Cap Stocks to Buy for June appeared first on InvestorPlace.

7 Undervalued Large-Cap Stocks to Buy for June

S&P Global

Falling prices can be good for your wallet. Wait, what?

Dividend Investor? Embrace The Bear Market

Atmos Energy

Colgate-Palmolive

Johnson & Johnson

Kraft Heinz

Kimberly-Clark

Kroger

McDonald's

AT&T

If there is one voice on Wall Street that we always listen to, it is Stifel's Barry Bannister.

Legendary Wall Street Strategist Says Buy Defensive Value Now: 9 Dividend Stocks Fit the Bill

AbbVie

These stocks could be good places to park your money.

2 Dividend Kings That Are Soundly Beating the Market in 2022

Cardinal Health

Chevron

Lumen Technologies

Magellan Midstream Partners

Medical Properties Trust

Highest-yielding dividend stocks offer add stability and consistent returns to portfolios The post The 7 Highest-Yielding Dividend Stocks to Buy Now for Income appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn't matter if you have $500 in savings or $5 million.

The 7 Highest-Yielding Dividend Stocks to Buy Now for Income

Consumer Staples Select Sector SPDR Fund

Instead of being the safe haven, the consumer staple sector is going through extreme volatility now with its leading stocks facing headwinds. The large correction recently has brought the sector, as represented by the Consumer Staples Select Sector SPDR Fund, into a reasonable valuation.

Consumer Staples Panic: XLP And Altria In Focus

Shares of Altria dipped about 8% in May after Philip Morris announced it wants to acquire Swedish Match for $16B. The deal stoked fears that competition for Altria's oral tobacco category will ramp up going forward. This is likely not going to be the case.

Altria's 7% Yield Is A Strong Buy, Here's Why

Altria Group (NYSE:MO) and British American Tobacco Industries (LON:BATS) are two stocks that will hold up well in the declining market. Altria Group is trading at $51.09.

Does BAT offer a better investment opportunity in a declining market?

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA HOLDS 2022 ANNUAL MEETING OF SHAREHOLDERS; REAFFIRMS 2022 FULL-YEAR EARNINGS GUIDANCE; DECLARES REGULAR QUARTERLY DIVIDEND OF $0.90 PER SHARE

Altria Holds 2022 Annual Meeting of Shareholders; Reaffirms 2022 Full-Year Earnings Guidance; Declares Regular Quarterly Dividend of $0.90 Per Share

Philip Morris

With the market crashing blue-chip bargains are raining from the sky, and investors have to be selective with what they buy. MO and PM are defensive, low volatility dividend kings and both are up about 14% this year.

Altria Vs. Philip Morris: The Better Buy Might Surprise You

Albertsons Companies

Clearway Energy

HealthStream

Coca-Cola

National HealthCare

NRG Energy

PG&E

Regencell Bioscience Holdings Ltd

Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising interest rates and the bond market's inverted yield curve.

Sector Rotation And 9 Stocks To Watch During A Recession

Advanced Semiconductor Engineering

Manulife Financial

Merck

Prudential Financial

Investors looking for retirement stocks should look for companies with high growth and steady income and shun risky, unproven stocks. The post 7 Retirement Stocks for Steady Long-Term Income Growth appeared first on InvestorPlace.

7 Retirement Stocks for Steady Long-Term Income Growth

British American Tobacco

Cummins

Enbridge

Enterprise Products Partners

V.F.

The speed of this bear market is history, though the actual declines are merely normal, average, and completely expected. When it's raining blue-chip bargains from the sky, smart investors know to bend it like Buffett and buy, buy, buy.

6% Yielding Blue-Chip Bargains I'm Buying Hand Over Fist

Vector Group

Altria's and Vector's shares fell 7% and 13%, respectively, on seemingly insignificant news. At just 2% of Altria's market cap, Vector could be viewed as an undiscovered gem in this space, while tobacco majors have posted solid gains in recent months.

Which Company Should You Bet On After The Sell-Off - Altria Or Vector?

Shares of Altria Group Inc. took a dive Tuesday, after the cigarettes seller was downgraded at Bernstein, which citing increasing concerns over competition with its former subsidiary, Philip Morris International Inc.

Altria stock dives as a ‘Cold War' developing with Philip Morris prompts analyst downgrade

First of Long Island

Fresenius Medical Care

Lowe's

Polaris

SEI Investments

Stanley Black & Decker

The markets are in turmoil, crashing at rates that have shocked even market veterans. Half of the Nasdaq is down 50+% and over 20% is down 75+%. Even some dividend aristocrats have fallen 30% to 40% in 2022.

My, Oh My, 10 Dividend Aristocrat Strong Buys

Ambev

B&G Foods

Big Lots

U.S. markets suffered a bloodbath on Monday. The S&P 500 index fell below 4,000 to finish at its lowest point in a year, the Nasdaq Composite plunged by 4.3% and the Dow Jones industrials lost 2.0%.

5 Top Defensive Stocks to Help Ride Out the Market Downturn

Realty Income Corp

Royal Bank of Canada

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

The 2022 bear market rages on, with the 3rd worst start to the year for stocks in history. Growth stocks are getting wrecked but low volatility, high-yield blue-chips offer a shelter in the storm.

9 High-Yield Blue-Chips To Help You Sleep Well At Night In This Bear Market

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA TO HOST WEBCAST OF 2022 ANNUAL MEETING OF SHAREHOLDERS

Altria to Host Webcast of 2022 Annual Meeting of Shareholders

News for Altria Stock (MO)